Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO & Treasurer

President and CEO

Chief Operating Officer

Chief Technology Officer

Chief Regulatory Officer

Chief Scientific Officer

Solid Biosciences Inc., a life science company, engages in developing therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, a next-generation gene transfer candidate for the treatment of Duchenne muscular dystrophy (Duchenne); AVB-202-TT, a gene therapy program for the treatment of Friedreich's ataxia; AVB-401, a gene therapy program for the treatment of BAG3-mediated dilated cardiomyopathy; and other drugs for the treatment of undisclosed cardiac diseases. It also engages in developing platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Solid Biosciences Inc., a life science company, engages in developing therapies for neuromuscular and cardiac diseases in the United State...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-02	Premium	acquired	Premium	Premium	Premium	-
2024-05-02	Premium	sold	Premium	Premium	Premium	-
2024-04-03	Premium	acquired	Premium	Premium	Premium	-
2024-01-29	Premium	sold	Premium	Premium	Premium	-
2024-01-27	Premium	acquired	Premium	Premium	Premium	-
2024-01-27	Premium	acquired	Premium	Premium	Premium	-
2024-01-11	Premium	bought	Premium	Premium	Premium	-
2024-01-11	Premium	acquired	Premium	Premium	Premium	-
2024-01-11	Premium	acquired	Premium	Premium	Premium	-
2024-01-11	Premium	bought	Premium	Premium	Premium	-
2024-01-09	Premium	acquired	Premium	Premium	Premium	CFO & Treasurer
2024-01-09	Premium	sold	Premium	Premium	Premium	CFO & Treasurer
2024-01-03	Premium	acquired	Premium	Premium	Premium	-
2024-01-03	Premium	sold	Premium	Premium	Premium	-
2024-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-12-04	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-04	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-12-04	Premium	sold	Premium	Premium	Premium	CSO
2023-12-04	Premium	sold	Premium	Premium	Premium	Chief Technology Officer
2023-12-04	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2023-12-02	Premium	acquired	Premium	Premium	Premium	-
2023-12-02	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-02	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-12-02	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2023-12-02	Premium	acquired	Premium	Premium	Premium	Chief Technology Officer

SLDB - Solid Biosciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SLDB